1-800 CONTACTS Announces Resolution to Supply Issue
31 Enero 2007 - 3:00PM
PR Newswire (US)
DRAPER, Utah, Jan. 31 /PRNewswire-FirstCall/ -- 1-800 CONTACTS,
INC. (NASDAQ:CTAC), today announced that it has resolved its
longstanding supply issue. (Logo:
http://www.newscom.com/cgi-bin/prnh/20040107/LACONTACTSLOGO) The
Company has recently signed long-term supply agreements with its
three largest contact lens suppliers. The Company has purchased
directly from Bausch & Lomb, its fourth largest supplier,
without a written agreement since 2001. Based on this longstanding
relationship and recent discussions with Bausch & Lomb, the
Company does not expect this direct relationship to change.
Jonathan Coon, Chief Executive Officer, commented, "For the first
time in the Company's history, we can now purchase directly, as an
authorized account, every lens marketed by the four largest
manufacturers. We believe these four manufacturers represent
approximately 98% of all soft contact lenses sold in the United
States. "Six years ago, our small company began dedicating
tremendous resources to support the right of consumers to have an
automatic right to their prescriptions and the right to use their
prescriptions wherever they choose -- because we want to be one of
those choices. We spent years engaged in litigation to support this
right. We then spent years longer supporting, and working for,
federal and state legislation aimed at guaranteeing this right.
"Today, 36 million Americans who wear contact lenses are protected
by the Fairness to Contact Lens Consumers Act (FCLCA) which grants
them an automatic right to their prescriptions, and the right to
have their prescriptions verified when they purchase from a seller
other than their eye doctor. In passing the FCLCA, Congress said in
the accompanying report language, 'The consumer's right to a copy
of their contact lens prescription means nothing unless consumers
can fill that prescription at the business of their choice.' "In
its most recent session, to ensure that consumers could fill their
prescriptions from the business of their choice, Congress
considered legislation regarding contact lens distribution
practices. We supported that legislation. However, we believe the
market solution embodied in these recent supply agreements is
adequate to ensure a competitive market -- making legislation
unnecessary at this time. "As the eye care industry focuses more on
consumer needs, the entire industry, and, more importantly, the 36
million Americans who wear contact lenses, will benefit. This focus
on consumers is apparent on the part of manufacturers, who over the
past few years have introduced innovative new products that provide
real, consumer-noticeable benefits. We believe these changes in the
regulatory and industry environment will create a competitive
market that results in more contact lens wearers, fewer dropouts,
and better patient compliance (more frequent replacement)." Brian
Bethers, President, added, "We also need to update our shareholders
on a recent development with one of our top selling lenses that
represents approximately 4% of our sales. On January 12th, one of
our largest suppliers announced manufacturing difficulties with
this lens ( http://www.jan12statement.com/ ). This supplier states
in this notice that it expects significant supply constraints and
backorders into the second quarter. We are already experiencing
difficulties filling orders for this lens and are uncertain how
this supply disruption will affect our customers and our business
in the first half of the year." Mr. Bethers continued, "This
resolution to our years of legal and legislative efforts allows us
to refocus the Company's resources and management's time on serving
customers and growing our business. We expect the large amounts of
our selling, general, and administrative expenses that have for
years been dedicated to legislative and legal initiatives will
decrease. However, it will take time to rebuild our business with
customers we have not been able to serve for years. For this
reason, and due to the uncertainty associated with the supply
disruption for one of our top selling lenses, we are not revising
our prior guidance for 2007." About 1-800 CONTACTS, INC. 1-800
CONTACTS offers consumers an attractive alternative for obtaining
replacement contact lenses in terms of convenience, price and speed
of delivery. Through its easy-to-remember, toll-free telephone
number, "1-800 CONTACTS" (1-800-266-8228), and its Internet web
site, http://www.1800contacts.com/, the Company sells almost all of
the popular brands of contact lenses. 1-800 CONTACTS offers
products at competitive prices, while delivering a high level of
customer service. The Company has delivered more than 15 million
orders to over 5 million customers. Forward-looking Statements This
news release contains a number of forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995. Such statements include, but are not limited to: statements
relating to resolution of longstanding supply issues; our
anticipated ability to purchase contact lenses directly from our
largest contact lens suppliers; our expectation that our ability to
purchase lenses directly from Bausch & Lomb will not change;
our belief that the agreements referred to in this news release
reflect a market solution making legislation unnecessary at this
time; our belief that regulatory and industry changes will create a
competitive market that results in more frequent lens replacement;
our anticipated ability to refocus the Company's resources on
serving customers and growing our business; our expectation that
the resources we dedicate to legislative and legal initiatives will
decrease; our prior guidance for 2007; and all other statements
that are not purely historical. All such forward-looking statements
are based upon information available to us as of the date hereof,
and we disclaim any intention or obligation to update any such
forward-looking statements. All of our forward-looking statements
are subject to risks and uncertainties that could cause actual
results to differ materially from those set forth in or implied by
such forward-looking statements. These risks and uncertainties
include, among others: general economic conditions, the health and
size of the contact lens industry, inventory acquisition and
management, manufacturing operations, governmental regulations,
exchange rate fluctuations, advertising spending and effectiveness,
unanticipated costs and expected benefits associated with the
Japanese license agreement and our supply agreements and related
arrangements, research and development initiatives, prescription
verification requirements of The Fairness to Contact Lens Consumers
Act, other regulatory considerations, and the other risks and
uncertainties identified in the reports we have filed from time to
time with the U.S. Securities and Exchange Commission, including
our most recent Annual Report on Form 10-K and Quarterly Report on
Form 10-Q. Information on our websites, other than the information
specifically referenced in this press release, shall not be deemed
to be part of this press release.
http://www.newscom.com/cgi-bin/prnh/20040107/LACONTACTSLOGO
http://photoarchive.ap.org/ DATASOURCE: 1-800 CONTACTS, INC.
CONTACT: Brian W. Bethers, President, or Robert G. Hunter, CFO,
both of 1-800 CONTACTS, INC., +1-801-316-5000, Web site:
http://www.1800contacts.com/ http://www.jan12statement.com/
Copyright
ChaSerg Technology Acqui... (NASDAQ:CTAC)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
ChaSerg Technology Acqui... (NASDAQ:CTAC)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024